https://ibmm.umontpellier.fr/wp-content/uploads/2026/09/Capture-decran-2026-09-08-154324.png
527
1007
Caroline Clavel
https://ibmm2.umontpellier.fr/wp-content/uploads/logo_ibmm_hd.jpg
Caroline Clavel2026-09-08 16:09:102026-09-08 16:09:10HyriaMed: a new start-up stemming from research by the PHBM team- Read more
The Institut des Biomolécules Max Mousseron (IBMM, UMR 5247) is a research unit of UM, CNRS and ENSCM that develops research at the interface of chemistry, biology and health, integrating the challenges of sustainable development: feed, cure, protect.

News
https://ibmm.umontpellier.fr/wp-content/uploads/2026/09/Capture-decran-2026-09-08-154324.png
527
1007
Caroline Clavel
https://ibmm2.umontpellier.fr/wp-content/uploads/logo_ibmm_hd.jpg
Caroline Clavel2026-09-08 16:09:102026-09-08 16:09:10HyriaMed: a new start-up stemming from research by the PHBM team
Breast Cancer: Jean-Marie Ramirez Presents an Innovative Implant to Prevent Metastasis
How can cancer cells be prevented from leaving…
Job/training
16 research teams

Glycochemistry & molecular recognition
30 March 2024/by Stephanie HERNANDEZ
Amino acids, heterocycles, peptides & proteins
30 March 2024/by Stephanie HERNANDEZ
Analytical Sciences of Biomolecules
30 March 2024/by Stephanie HERNANDEZ
Bioactive Lipids Syntheses
30 March 2024/by Stephanie HERNANDEZ
Nucleosides & Phosphorylated Effectors
30 March 2024/by Stephanie HERNANDEZ
Oncotherapy and Oncopharmacology
19 December 2024/by Caroline Clavel
Dynamics of Complex Biomolecular Systems
30 March 2024/by Stephanie HERNANDEZ
Green Chemistry and Enabling Technologies
30 March 2024/by Stephanie HERNANDEZ
ChemBioNAC
30 March 2024/by Stephanie HERNANDEZ
Polymers for Health and Biomaterials
30 March 2024/by Stephanie HERNANDEZ
Glyco and nanovectors for therapeutic targeting
30 March 2024/by Stephanie HERNANDEZ
Oncopharmacochemy & Skin Pharmacotoxicology
6 April 2024/by Stephanie HERNANDEZ
Pharmacochemistry Synaptic Transmission & Neuroprotection
30 March 2024/by Stephanie HERNANDEZ
Stereoselective Synthesis & Modified Amino Acids
30 March 2024/by Stephanie HERNANDEZ
Cellular pharmacology
30 March 2024/by Stephanie HERNANDEZ







Stage M2/3A : Biomatériaux hybrides pour le traitement du cancer de la prostate par thérapie combinée (Copie)
Host Team PHBM Team – Polymers for Health and Biomaterials, IBMM https://ibmm.umontpellier.fr/en/polymers-for-health-and-biomaterials/ Pôle Chimie Balard Recherche 1919 route de mende 34293 Montpellier Cedex 5 Internship Supervisors Contact Benjamin Nottelet / Hélène Van Den Berghe +33(0)4-48-79-20-39 / +33(0)4-48-79-20-41 / Keywords Polyesters, polysaccharides, nanoparticles, hydrogels, drug formulation. Skills Acquired by the Student by […]
Internship M2 : Development of Recombinant Collagen Hydrogels for 3D Organoid Culture
Period: 6 months from January/February to June/July 2027Internship supervisors: Dr Penthip Muangkaew and Dr Cécile EchalierContact: team: IBMM Peptides www.ibmmpeptide.comInternship location: IBMM, Pole Chimie Balard, 1919 Route de Mende, Montpellier, France. Summary 3D organoids and tumoroids derived from patient cells have emerged as a powerful alternative to 2D cultures and animal testing. Because cell-matrix […]